Venous Thromboembolism Global Clinical Trials Review, H1, 2012

Venous Thromboembolism Global Clinical Trials Review, H1, 2012


January 27, 2012
104 Pages - SKU: GBDT6797496
License type:
Online Download      US $1,000.00
Global Site License      US $3,000.00
Venous Thromboembolism Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H1, 2012 provides data on the Venous Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous Thromboembolism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Venous Thromboembolism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



More Drug Discovery reports by GlobalData

Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 by GlobalData
Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 provides data ...
Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014 by GlobalData
Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014 provides data on the ...
EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022 by GlobalData
EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022SummaryAnkylosing spondylitis is a systemic, chronic, and progressive inflammatory arthritis in the family of seronegativespondyloarthritis, and is ...
OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017 by GlobalData
OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017SummaryWith five-year survival only approximately 5%, pancreatic cancer is characterized as a disease with some of ...
See all reports like this >>